Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Personal Finance Center Mortgages Loans Investing & Retirement Spending & Savings

Calculators

401k Retirement Calculator Mortgage Calculator

Compound Interest Calculator Dollar Cost Averaging

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

News Smart Portfolio Expert Center TipRanksAI

TOOLS

Earnings Calendar

Daily Analyst Ratings

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

XOMA Stock Latest News

Biotech Alert: Searches spiking for these stocks today

The FlyBiotech Alert: Searches spiking for these stocks today

Xoma acquires economic interest in three assets from Dare Bioscience

PremiumThe Fly

Xoma acquires economic interest in three assets from Dare Bioscience

10d ago

Dare Bioscience secures $22M in non-dilutive strategic royalty financing

PremiumThe Fly

Dare Bioscience secures $22M in non-dilutive strategic royalty financing

10d ago

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%

PremiumPress Releases

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%

10d ago

Xoma initiated with an Outperform at Leerink

PremiumThe Fly

Xoma initiated with an Outperform at Leerink

11d ago

$XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)$

PremiumPress ReleasesXOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)

15d ago

Xoma earns $9M milestone as FDA grants approval of Day One’s NDA for OJEMDA

PremiumThe Fly

Xoma earns $9M milestone as FDA grants approval of Day One’s NDA for OJEMDA

15d ago

Xoma announces closing of tender offer

PremiumThe Fly

Xoma announces closing of tender offer

1M ago

XOMA Corporation Announces Closing of Tender Offer

PremiumPress Releases

XOMA Corporation Announces Closing of Tender Offer

1M ago

XOMA Declares Quarterly Preferred Stock Dividends

PremiumPress Releases

XOMA Declares Quarterly Preferred Stock Dividends

2M ago

XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.

PremiumPress Releases

XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.

2M ago

Xoma Corp. Is Worried About This – Should You Be Worried Too?

PremiumCompany Announcements

Xoma Corp. Is Worried About This – Should You Be Worried Too?

2M ago

Xoma files $200M mixed securities shelf

PremiumThe FlyXoma files $200M mixed securities shelf

2M ago

XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value

PremiumPress Releases

XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value

2M ago

Xoma reports 2023 EPS ($4.04) vs. ($1.98) last year

PremiumThe Fly

Xoma reports 2023 EPS ($4.04) vs. ($1.98) last year

2M ago

Is XOMA a Buy, Before Earnings?

PremiumPre-Earnings

Is XOMA a Buy, Before Earnings?

2M ago

XOMA to Present at Upcoming Investor Conferences in March

PremiumPress Releases

XOMA to Present at Upcoming Investor Conferences in March

2M ago

Kinnate Biopharma price target raised to $2.59 from $1.50 at Stifel

PremiumThe Fly

Kinnate Biopharma price target raised to $2.59 from $1.50 at Stifel

2M ago

Xoma acquisition boosts royalty growth potential, says H.C. Wainwright

PremiumThe Fly

Xoma acquisition boosts royalty growth potential, says H.C. Wainwright

3M ago

Xoma Corp Secures Merger with Kinnate Biopharma Inc.

PremiumCompany AnnouncementsXoma Corp Secures Merger with Kinnate Biopharma Inc.

3M ago

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right

PremiumPress Releases

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right

3M ago

Xoma to acquire Kinnate for between $2.3352-$2.5879 per share plus CVR

PremiumThe Fly

Xoma to acquire Kinnate for between $2.3352-$2.5879 per share plus CVR

3M ago

Trending

S&P 500

Dow Jones

Nasdaq 100

More Trending Stocks >